Hemanext
PrivateLast Round
Grant
Oct 14, 2025
Est. Valuation
$172M
Total Funding Raised
$100.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Hemanext is a medical technology company that develops oxygen-controlled processing and storage systems to preserve the quality and function of red blood cells for transfusion.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hemanext Comparables
Compare Hemanext with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cerus Corporation | 76% | |
| Haemonetics | 71% | |
| Terumo Corporation | 71% |
Hemanext Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 14, 2025 | ||||
| Series B Extension | Jul 22, 2025 | ||||
| Series B Extension | Jan 27, 2025 | ||||
| Series B Extension | Oct 1, 2024 | ||||
| Strategic | Jun 7, 2023 | ||||
Series B | Nov 7, 2022 |
Key People
Founding team and executive leadership
Hemanext Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| National Heart, Lung, and Blood Institute | Grant |
| Antaeus Enterprises, Inc. | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors grew 40% MoM.
- Oct 14, 2025
$3M grant from the National Heart, Lung, and Blood Institute.
Recent news
Latest coverage and updates
- partners_withJul 6, 2026
Hemanext Inc. partnered with OneBlood, Inc. on Jul 6th '26.
Hemanext Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Hemanext's valuation, stock price, and market status.
Is Hemanext a public or private company?
Hemanext is a private company.
What is the current stock price of Hemanext?
Hemanext is a private company with no public stock price. No recent secondary market data is available.
How much is Hemanext worth (valuation)?
Hemanext's valuation is estimated at $172.0M based on funding round data.
Can I buy Hemanext stock?
Hemanext shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Hemanext's last funding round?
Hemanext's most recent funding round was Series B Extension on July 22, 2025.
Who are the main investors in Hemanext?
Key investors in Hemanext include Antaeus Enterprises, Inc..
Will Hemanext IPO soon?
No public IPO plans have been announced for Hemanext.
How can I track Hemanext secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hemanext's secondary market activity and sign up for updates.